SCHEMBL12943881

SCHEMBL12943881

BC(=O)c1cc(C(=O)O)[nH]n1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
ALPL P05186 9/20 0.44
CA12 O43570 5/20 0.44
MAPK1 P28482 1/20 0.44
HCAR2 Q8TDS4 4/20 0.44
DAO P14920 1/20 0.44
RPA1 P27694 1/20 0.43
HCAR3 P49019 2/20 0.42
PIN1 Q13526 1/20 0.42
CA9 Q16790 2/20 0.41
CYTH3 O43739 1/20 0.40
BTK Q06187 1/20 0.40
EPN1 Q9Y6I3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70577 0.85 HCAR2 (0.59) TP53ALPLCA12MAPK1HCAR2
SCHEMBL8068037 0.83 ALPL (0.47) TP53ALPLCA12MAPK1HCAR2
Water SCHEMBL1267709 0.83 HCAR2 (0.57) TP53ALPLCA12MAPK1HCAR2
Hydrochloric Acid SCHEMBL11595364 0.83 HCAR2 (0.57) TP53ALPLCA12MAPK1HCAR2
Hydrochloric Acid SCHEMBL7723258 0.83 HCAR2 (0.57) TP53ALPLCA12MAPK1HCAR2
SCHEMBL28638090 0.83 HCAR2 (0.57) TP53ALPLCA12MAPK1HCAR2
SCHEMBL19987833 0.83 HCAR2 (0.57) TP53ALPLCA12MAPK1HCAR2
Ammonia Solution, Strong SCHEMBL28463590 0.81 HCAR2 (0.55) TP53ALPLCA12MAPK1HCAR2
SCHEMBL8068032 0.79 TP53 (0.47) TP53ALPLCA12MAPK1HCAR2
SCHEMBL1815487 0.79 MAPK1 (0.48) TP53ALPLCA12MAPK1HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451450-B1 Inhibitors of proline racemase enzymes for the treatment of Trypanosoma spp infections PASTEUR INSTITUT (FR) 2014-07-02 EP disclosed
WO-2011004323-A1 NEW INHIBITORS OF PROLINE RACEMASE ENZYMES INSTITUT PASTEUR (FR) 2011-01-13 WO disclosed